Jeff Evanson

Insider Reports History

Location
Cranbury, NJ
Signature
/s/ Lawrence Kenyon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeff Evanson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Outlook Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Common Stock 808K $340K $0.42 07 Mar 2024 Direct
Outlook Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Stock Option (Right to Buy) 25K 20 Mar 2024 Direct

Insider Reports Filed by Jeff Evanson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OTLK Outlook Therapeutics, Inc. 20 Mar 2024 1 $0 4 CHIEF COMMERCIAL OFFICER 22 Mar 2024, 17:00
OTLK Outlook Therapeutics, Inc. 07 Mar 2024 1 $26.2K 4 CHIEF COMMERCIAL OFFICER 11 Mar 2024, 16:43
OTLK Outlook Therapeutics, Inc. 17 Apr 2023 1 $0 4 Chief Commercial Officer 19 Apr 2023, 17:41
OTLK Outlook Therapeutics, Inc. 20 Jan 2023 1 -$296K 4 Chief Commercial Officer 24 Jan 2023, 19:08
OTLK Outlook Therapeutics, Inc. 17 Jan 2023 3 -$204K 4 Chief Commercial Officer 19 Jan 2023, 19:05
OTLK Outlook Therapeutics, Inc. 31 Mar 2022 1 $0 4 Chief Commercial Officer 04 Apr 2022, 18:47
OTLK Outlook Therapeutics, Inc. 21 Dec 2021 1 $0 4 Chief Commercial Officer 23 Dec 2021, 16:32
OTLK Outlook Therapeutics, Inc. 03 Dec 2021 1 $47.2K 4 Chief Commercial Officer 06 Dec 2021, 16:25